This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Maggini S., Wintergerst E.S., Beveridge S., Hornig D.H.: Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br. J. Nutr., 2007; 98: S29–S35.MagginiS.WintergerstE.S.BeveridgeS.HornigD.H.Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responsesBr. J. Nutr.200798S29S3510.1017/S0007114507832971Search in Google Scholar
Padayatty S.J., Levine M.: Vitamin C: The known and the unknown and goldilocks. Oral Dis., 2016; 22: 463–493.PadayattyS.J.LevineM.Vitamin C: The known and the unknown and goldilocksOral Dis.20162246349310.1111/odi.12446Search in Google Scholar
Smirnoff N., Wheeler G.L.: Ascorbic acid in plants: Biosynthesis and function. Crit. Rev. Biochem. Mol. Biol., 2000; 35: 291–314.SmirnoffN.WheelerG.L.Ascorbic acid in plants: Biosynthesis and functionCrit. Rev. Biochem. Mol. Biol.20003529131410.1080/10409230008984166Search in Google Scholar
Vissers M.C., Das A.B.: Potential mechanisms of action for vitamin C in cancer: Reviewing the evidence. Front Physiol., 2018; 9: 809.VissersM.C.DasA.B.Potential mechanisms of action for vitamin C in cancer: Reviewing the evidenceFront Physiol.2018980910.3389/fphys.2018.00809Search in Google Scholar
González M.J., Miranda-Massari J.R., Mora E.M., Guzmán A., Riordan N.H., Riordan H.D., Casciari J.J., Jackson J.A., Román-Franco A.: Orthomolecular oncology review: Ascorbic acid and cancer 25 years later. Integr. Cancer Ther., 2005; 4: 32–44.GonzálezM.J.Miranda-MassariJ.R.MoraE.M.GuzmánA.RiordanN.H.RiordanH.D.CasciariJ.J.JacksonJ.A.Román-FrancoA.Orthomolecular oncology review: Ascorbic acid and cancer 25 years laterIntegr. Cancer Ther.20054324410.1177/1534735404273861Search in Google Scholar
Blaszczak W., Barczak W., Masternak J., Kopczyński P., Zhitkovich A., Rubiś B.: Vitamin C as a modulator of the response to cancer therapy. Molecules, 2019; 24: 453.BlaszczakW.BarczakW.MasternakJ.KopczyńskiP.ZhitkovichA.RubiśB.Vitamin C as a modulator of the response to cancer therapyMolecules20192445310.3390/molecules24030453Search in Google Scholar
Klimant E., Wright H., Rubin D., Seely D., Markman M.: Intravenous vitamin C in the supportive care of cancer patients: A review and rational approach. Curr. Oncol., 2018; 25: 139–148.KlimantE.WrightH.RubinD.SeelyD.MarkmanM.Intravenous vitamin C in the supportive care of cancer patients: A review and rational approachCurr. Oncol.20182513914810.3747/co.25.3790Search in Google Scholar
Monti D.A., Mitchell E., Bazzan A.J., Littman S., Zabrecky G., Yeo C.J., Pillai M.V., Newberg A.B., Deshmukh S., Levine M.: Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One, 2012; 7: e29794.MontiD.A.MitchellE.BazzanA.J.LittmanS.ZabreckyG.YeoC.J.PillaiM.V.NewbergA.B.DeshmukhS.LevineM.Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancerPLoS One20127e2979410.1371/journal.pone.0029794Search in Google Scholar
Wang H., Dutta B., Huang W., Devoe L.D., Leibach F.H., Ganapathy V., Prasad P.D.: Human Na+-dependent vitamin C transporter 1 (hSVCT1): Primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim. Biophys. Acta, 1999; 1461: 1–9.WangH.DuttaB.HuangW.DevoeL.D.LeibachF.H.GanapathyV.PrasadP.D.Human Na+-dependent vitamin C transporter 1 (hSVCT1): Primary structure, functional characteristics and evidence for a non-functional splice variantBiochim. Biophys. Acta199914611910.1016/S0005-2736(99)00182-0Search in Google Scholar
Bánhegyi G., Benedetti A., Margittai E., Marcolongo P., Fulceri R., Németh C.E., Szarka A.: Subcellular compartmentation of ascorbate and its variation in disease states. Biochim. Biophys. Acta, 2014; 1843: 1909–1916.BánhegyiG.BenedettiA.MargittaiE.MarcolongoP.FulceriR.NémethC.E.SzarkaA.Subcellular compartmentation of ascorbate and its variation in disease statesBiochim. Biophys. Acta201418431909191610.1016/j.bbamcr.2014.05.01624907663Search in Google Scholar
Cantuaria G., Fagotti A., Ferrandina G., Magalhaes A., Nadji M., Angioli R., Penalver M., Mancuso S., Scambia G.: GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy. Cancer, 2001; 92: 1144–1150.CantuariaG.FagottiA.FerrandinaG.MagalhaesA.NadjiM.AngioliR.PenalverM.MancusoS.ScambiaG.GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapyCancer2001921144115010.1002/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-TSearch in Google Scholar
Yun J., Mullarky E., Lu C., Bosch K.N., Kavalier A., Rivera K., Roper J., Chio I.I., Giannopoulou E.G., Rago C., et al.: Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science, 2015; 350: 1391–1396.YunJ.MullarkyE.LuC.BoschK.N.KavalierA.RiveraK.RoperJ.ChioI.I.GiannopoulouE.G.RagoC.Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHScience20153501391139610.1126/science.aaa5004Search in Google Scholar
Lv H., Wang C., Fang T., Li T., Lv G., Han Q., Yang W., Wang H.: Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. NPJ Precis. Oncol., 2018; 2: 1.LvH.WangC.FangT.LiT.LvG.HanQ.YangW.WangH.Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2NPJ Precis. Oncol.20182110.1038/s41698-017-0044-8Search in Google Scholar
Chong T.L., Ahearn E.L., Cimmino L.: Reprogramming the epigenome with vitamin C. Front. Cell Dev. Biol., 2019; 7: 128.ChongT.L.AhearnE.L.CimminoL.Reprogramming the epigenome with vitamin CFront. Cell Dev. Biol.2019712810.3389/fcell.2019.00128Search in Google Scholar
Howe G.R., Hirohata T., Hislop T.G., Iscovich J.M., Yuan J.M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T., et al.: Dietary factors and risk of breast cancer: Combined analysis of 12 case–control studies. J. Natl. Cancer Inst., 1990; 82: 561–569.HoweG.R.HirohataT.HislopT.G.IscovichJ.M.YuanJ.M.KatsouyanniK.LubinF.MarubiniE.ModanB.RohanT.Dietary factors and risk of breast cancer: Combined analysis of 12 case–control studiesJ. Natl. Cancer Inst.19908256156910.1093/jnci/82.7.561Search in Google Scholar
Block G.: Vitamin C and cancer prevention: The epidemiologic evidence. Am. J. Clin. Nutr., 1991; 53: 270S–282S.BlockG.Vitamin C and cancer prevention: The epidemiologic evidenceAm. J. Clin. Nutr.199153270S282S10.1093/ajcn/53.1.270SSearch in Google Scholar
Xi D.: Vitamin C in cancer therapeutics and metastasis. J. Orthop. Res. Ther., 2019; 10: 1127.XiD.Vitamin C in cancer therapeutics and metastasisJ. Orthop. Res. Ther.2019101127Search in Google Scholar
Notani P.N., Jayant K.: Role of diet in upper aerodigestive tract cancers. Nutr. Cancer, 1987; 10: 103–113.NotaniP.N.JayantK.Role of diet in upper aerodigestive tract cancersNutr. Cancer19871010311310.1080/01635588709513945Search in Google Scholar
Bo Y., Lu Y., Zhao Y., Zhao E., Yuan L., Lu W., Cui L., Lu Q.: Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis. Int. J. Cancer, 2016; 138: 1843–1850.BoY.LuY.ZhaoY.ZhaoE.YuanL.LuW.CuiL.LuQ.Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysisInt. J. Cancer20161381843185010.1002/ijc.29838Search in Google Scholar
Fontham E.T., Pickle L.W., Haenszel W., Correa P., Lin Y.P., Falk R.T.: Dietary vitamins A and C and lung cancer risk in Louisiana. Cancer, 1988; 62: 2267–2273.FonthamE.T.PickleL.W.HaenszelW.CorreaP.LinY.P.FalkR.T.Dietary vitamins A and C and lung cancer risk in LouisianaCancer1988622267227310.1002/1097-0142(19881115)62:10<2267::AID-CNCR2820621033>3.0.CO;2-ESearch in Google Scholar
Hua Y.F., Wang G.Q., Jiang W., Huang J., Chen G.C., Lu C.D.: Vitamin C intake and pancreatic cancer risk: A meta-analysis of published case-control and cohort studies. PLoS One, 2016; 11: e0148816.HuaY.F.WangG.Q.JiangW.HuangJ.ChenG.C.LuC.D.Vitamin C intake and pancreatic cancer risk: A meta-analysis of published case-control and cohort studiesPLoS One201611e014881610.1371/journal.pone.0148816Search in Google Scholar
Lin P.H., Aronson W., Freedland S.J.: An update of research evidence on nutrition and prostate cancer. Urol. Oncol., 2019; 37: 387–401.LinP.H.AronsonW.FreedlandS.J.An update of research evidence on nutrition and prostate cancerUrol. Oncol.20193738740110.1016/j.urolonc.2017.10.006Search in Google Scholar
Hoang B.V., Lee J., Choi I.J., Kim Y.W., Ryu K.W., Kim J.: Effect of dietary vitamin C on gastric cancer risk in the Korean population. World J. Gastroenterol., 2016; 22: 6257–6267.HoangB.V.LeeJ.ChoiI.J.KimY.W.RyuK.W.KimJ.Effect of dietary vitamin C on gastric cancer risk in the Korean populationWorld J. Gastroenterol.2016226257626710.3748/wjg.v22.i27.6257Search in Google Scholar
Myung S.K., Ju W., Kim S.C., Kim H., Korean Meta-analysis (KORMA) Study Group: Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: A meta-analysis. BJOG, 2011; 118: 1285–1291.MyungS.K.JuW.KimS.C.KimH.Korean Meta-analysis (KORMA) Study GroupVitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: A meta-analysisBJOG20111181285129110.1111/j.1471-0528.2011.03032.xSearch in Google Scholar
Bai X.Y., Qu X., Jiang X., Xu Z., Yang Y., Su Q., Wang M., Wu H.: Association between dietary vitamin C intake and risk of prostate cancer: A meta–analysis involving 103,658 subjects. J. Cancer, 2015; 6: 913–921.BaiX.Y.QuX.JiangX.XuZ.YangY.SuQ.WangM.WuH.Association between dietary vitamin C intake and risk of prostate cancer: A meta–analysis involving 103,658 subjectsJ. Cancer2015691392110.7150/jca.12162Search in Google Scholar
Zhang S., Hunter D.J., Forman M.R., Rosner B.A., Speizer F.E., Colditz G.A., Manson J.E., Hankinson S.E., Willett W.C.: Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst., 1999; 91: 547–556.ZhangS.HunterD.J.FormanM.R.RosnerB.A.SpeizerF.E.ColditzG.A.MansonJ.E.HankinsonS.E.WillettW.C.Dietary carotenoids and vitamins A, C, and E and risk of breast cancerJ. Natl. Cancer Inst.19999154755610.1093/jnci/91.6.547Search in Google Scholar
Fulan H., Changxing J., Baina W.Y., Wencui Z., Chunqing L., Fan W., Dandan L., Dianjun S., Tong W., Da P., Yashuang Z.: Retinol, vitamins A, C, and E and breast cancer risk: A meta-analysis and meta-regression. Cancer Causes Control, 2011; 22: 1383–1396.FulanH.ChangxingJ.BainaW.Y.WencuiZ.ChunqingL.FanW.DandanL.DianjunS.TongW.DaP.YashuangZ.Retinol, vitamins A, C, and E and breast cancer risk: A meta-analysis and meta-regressionCancer Causes Control2011221383139610.1007/s10552-011-9811-ySearch in Google Scholar
Cui Y., Shikany J.M., Liu S., Shagufta Y., Rohan T.E.: Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women’s Health Initiative Observational Study. Am. J. Clin. Nutr., 2008; 87: 1009-1018.CuiY.ShikanyJ.M.LiuS.ShaguftaY.RohanT.E.Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women’s Health Initiative Observational StudyAm. J. Clin. Nutr.2008871009101810.1093/ajcn/87.4.1009Search in Google Scholar
Eichholzer M., Stähelin H.B., Gey K.F., Lüdin E., Bernasconi F.: Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int. J. Cancer, 1996; 66: 145–150.EichholzerM.StähelinH.B.GeyK.F.LüdinE.BernasconiF.Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel studyInt. J. Cancer19966614515010.1002/(SICI)1097-0215(19960410)66:2<145::AID-IJC1>3.0.CO;2-2Search in Google Scholar
Loria C.M., Klag M.J., Caulfield L.E., Whelton P.K.: Vitamin C status and mortality in US adults. Am. J. Clin. Nutr., 2000; 72: 139–145.LoriaC.M.KlagM.J.CaulfieldL.E.WheltonP.K.Vitamin C status and mortality in US adultsAm. J. Clin. Nutr.20007213914510.1093/ajcn/72.1.139Search in Google Scholar
Lin J., Cook N.R., Albert C., Zaharris E., Gaziano J.M., Van Denburgh M., Buring J.E., Manson J.E.: Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trial. J. Natl. Cancer Inst., 2009; 101: 14–23.LinJ.CookN.R.AlbertC.ZaharrisE.GazianoJ.M.Van DenburghM.BuringJ.E.MansonJ.E.Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trialJ. Natl. Cancer Inst.2009101142310.1093/jnci/djn438Search in Google Scholar
Myung S.K., Kim Y., Ju W., Choi H.J., Bae W.K.: Effects of antioxidant supplements on cancer prevention: Meta-analysis of randomized controlled trials. Ann. Oncol., 2010; 21: 166–179.MyungS.K.KimY.JuW.ChoiH.J.BaeW.K.Effects of antioxidant supplements on cancer prevention: Meta-analysis of randomized controlled trialsAnn. Oncol.20102116617910.1093/annonc/mdp286Search in Google Scholar
Park S.J., Myung S.K., Lee Y., Lee Y.J.: Effects of vitamin and antioxidant supplements in prevention of bladder cancer: A meta-analysis of randomized controlled trials. J. Korean Med. Sci., 2017; 32: 628–635.ParkS.J.MyungS.K.LeeY.LeeY.J.Effects of vitamin and antioxidant supplements in prevention of bladder cancer: A meta-analysis of randomized controlled trialsJ. Korean Med. Sci.20173262863510.3346/jkms.2017.32.4.628Search in Google Scholar
Jiang L., Yang K.H., Tian J.H., Guan Q.L., Yao N., Cao N., Mi D.H., Wu J., Ma B., Yang S.H.: Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: A meta-analysis of randomized controlled trials. Nutr. Cancer, 2010; 62: 719–727.JiangL.YangK.H.TianJ.H.GuanQ.L.YaoN.CaoN.MiD.H.WuJ.MaB.YangS.H.Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: A meta-analysis of randomized controlled trialsNutr. Cancer20106271972710.1080/01635581.2010.494335Search in Google Scholar
Myung S.K., Yang H.J.: Efficacy of vitamin and antioxidant supplements in prevention of esophageal cancer: Meta-analysis of randomized controlled trials. J. Cancer Prev., 2013; 18: 135–143.MyungS.K.YangH.J.Efficacy of vitamin and antioxidant supplements in prevention of esophageal cancer: Meta-analysis of randomized controlled trialsJ. Cancer Prev.20131813514310.15430/JCP.2013.18.2.135Search in Google Scholar
Pais R.; Dumitraşcu D.L.: Do antioxidants prevent colorectal cancer? A meta–analysis. Rom. J. Intern. Med., 2013; 51: 152–163.PaisR.DumitraşcuD.L.Do antioxidants prevent colorectal cancer? A meta–analysisRom. J. Intern. Med.201351152163Search in Google Scholar
Bjelakovic G., Nagorni A., Nikolova D., Simonetti R.G., Bjelakovic M., Gluud C.: Meta-analysis: Antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment. Pharmacol. Ther., 2006; 24: 281–291.BjelakovicG.NagorniA.NikolovaD.SimonettiR.G.BjelakovicM.GluudC.Meta-analysis: Antioxidant supplements for primary and secondary prevention of colorectal adenomaAliment. Pharmacol. Ther.20062428129110.1111/j.1365-2036.2006.02970.xSearch in Google Scholar
Cadeau C., Fournier A., Mesrine S., Clavel-Chapelon F., Fagherazzi G., Boutron–Ruault M.C.: Vitamin C supplement intake and postmenopausal breast cancer risk: Interaction with dietary vitamin C. Am. J. Clin. Nutr., 2016; 104: 228–234.CadeauC.FournierA.MesrineS.Clavel-ChapelonF.FagherazziG.Boutron–RuaultM.C.Vitamin C supplement intake and postmenopausal breast cancer risk: Interaction with dietary vitamin CAm. J. Clin. Nutr.201610422823410.3945/ajcn.115.126326Search in Google Scholar
Chang Y.J., Myung S.K., Chung S.T., Kim Y., Lee E.H., Jeon Y.J., Park C.H., Seo H.G., Huh B.Y.: Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: A meta-analysis of randomized controlled trials. Dermatology, 2011; 223: 36–44.ChangY.J.MyungS.K.ChungS.T.KimY.LeeE.H.JeonY.J.ParkC.H.SeoH.G.HuhB.Y.Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: A meta-analysis of randomized controlled trialsDermatology2011223364410.1159/000329439Search in Google Scholar
Katta R., Brown D.N.: Diet and skin cancer: The potential role of dietary antioxidants in nonmelanoma skin cancer prevention. J. Skin Cancer, 2015; 2015: 893149.KattaR.BrownD.N.Diet and skin cancer: The potential role of dietary antioxidants in nonmelanoma skin cancer preventionJ. Skin Cancer2015201589314910.1155/2015/893149Search in Google Scholar
Jamison J.M., Gilloteaux J., Taper H.S., Calderon P.B., Summers J.L.: Autoschizis: A novel cell death. Biochem. Pharmacol., 2002; 63: 1773–1783.JamisonJ.M.GilloteauxJ.TaperH.S.CalderonP.B.SummersJ.L.Autoschizis: A novel cell deathBiochem. Pharmacol.2002631773178310.1016/S0006-2952(02)00904-8Search in Google Scholar
Shenoy N., Bhagat T., Nieves E., Stenson M., Lawson J., Choudhary G.S., Habermann T., Nowakowski G., Singh R., Wu X., et al.: Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells. Blood Cancer J., 2017; 7: e587.ShenoyN.BhagatT.NievesE.StensonM.LawsonJ.ChoudharyG.S.HabermannT.NowakowskiG.SinghR.WuX.Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cellsBlood Cancer J.20177e58710.1038/bcj.2017.65554925728731456Search in Google Scholar
Capone M., Giannarelli D., Mallardo D., Madonna G., Festino L., Grimaldi A.M., Vanella V., Simeone E., Paone M., Palmieri G., et al.: Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. J. Immunother. Cancer, 2018; 6: 74.CaponeM.GiannarelliD.MallardoD.MadonnaG.FestinoL.GrimaldiA.M.VanellaV.SimeoneE.PaoneM.PalmieriG.Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumabJ. Immunother. Cancer201867410.1186/s40425-018-0383-1604871230012216Search in Google Scholar
McMillan D.C.: Systemic inflammation, nutritional status and survival in patients with cancer. Curr. Opin. Clin. Nutr. Metab. Care, 2009; 12: 223–226..McMillanD.C.Systemic inflammation, nutritional status and survival in patients with cancerCurr. Opin. Clin. Nutr. Metab. Care20091222322610.1097/MCO.0b013e32832a790219318937Search in Google Scholar
Kedzierska M., Olas B., Wachowicz B., Glowacki R., Bald E., Czernek U., Szydłowska-Pazera K., Potemski P., Piekarski J., Jeziorski A.: Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy. Fitoterapia, 2012; 83: 310–317.KedzierskaM.OlasB.WachowiczB.GlowackiR.BaldE.CzernekU.Szydłowska-PazeraK.PotemskiP.PiekarskiJ.JeziorskiA.Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapyFitoterapia20128331031710.1016/j.fitote.2011.11.007Search in Google Scholar
Hoffman F.A.: Micronutrient requirements of cancer patients. Cancer, 1985; 55: 295–300.HoffmanF.A.Micronutrient requirements of cancer patientsCancer19855529530010.1002/1097-0142(19850101)55:1+<295::AID-CNCR2820551315>3.0.CO;2-XSearch in Google Scholar
Mayland C.R., Bennett M.I., Allan K.: Vitamin C deficiency in cancer patients. Palliat. Med., 2005; 19: 17–20.MaylandC.R.BennettM.I.AllanK.Vitamin C deficiency in cancer patientsPalliat. Med.200519172010.1191/0269216305pm970oaSearch in Google Scholar
Mikirova N., Casciari J., Riordan N., Hunninghake R.: Clinical experience with intravenous administration of ascorbic acid: Achievable levels in blood for different states of inflammation and disease in cancer patients. J. Transl. Med., 2013; 11: 191.MikirovaN.CasciariJ.RiordanN.HunninghakeR.Clinical experience with intravenous administration of ascorbic acid: Achievable levels in blood for different states of inflammation and disease in cancer patientsJ. Transl. Med.20131119110.1186/1479-5876-11-191Search in Google Scholar
De Loecker W., Janssens J., Bonte J., Taper H.S.: Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. Anticancer Res., 1993; 13: 103–106.De LoeckerW.JanssensJ.BonteJ.TaperH.S.Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy actionAnticancer Res.199313103106Search in Google Scholar
Nakagawa K.: Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia. Cell. Mol. Biol., 2000, 46: 1375–1381.NakagawaK.Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemiaCell. Mol. Biol.20004613751381Search in Google Scholar
Calderon P.B., Cadrobbi J., Marques C., Hong-Ngoc N., Jamison J.M., Gilloteaux J., Summers J.L., Taper H.S.: Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Curr. Med. Chem., 2002; 9: 2271–2285.CalderonP.B.CadrobbiJ.MarquesC.Hong-NgocN.JamisonJ.M.GilloteauxJ.SummersJ.L.TaperH.S.Potential therapeutic application of the association of vitamins C and K3 in cancer treatmentCurr. Med. Chem.200292271228510.2174/0929867023368674Search in Google Scholar
Gilloteaux J., Jamison J.M., Neal D.R., Loukas M., Doberzstyn T., Summers J.L.: Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment with ascorbate and menadione. Ultrastruct. Pathol., 2010; 34: 140–160.GilloteauxJ.JamisonJ.M.NealD.R.LoukasM.DoberzstynT.SummersJ.L.Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment with ascorbate and menadioneUltrastruct. Pathol.20103414016010.3109/01913121003662304Search in Google Scholar
Tareen B., Summers J.L., Jamison J.M., Neal D.R., McGuire K., Gerson L., Diokno A.: A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int. J. Med. Sci., 2008; 5: 62–67.TareenB.SummersJ.L.JamisonJ.M.NealD.R.McGuireK.GersonL.DioknoA.A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapyInt. J. Med. Sci.20085626710.7150/ijms.5.62Search in Google Scholar
Magrì A., Germano G., Lorenzato A., Lamba S., Chilà R., Montone M., Amodio V., Ceruti T., Sassi F., Arena S., et al.: High-dose vitamin C enhances cancer immunotherapy. Sci. Transl. Med., 2020; 12: eaay8707.MagrìA.GermanoG.LorenzatoA.LambaS.ChilàR.MontoneM.AmodioV.CerutiT.SassiF.ArenaS.High-dose vitamin C enhances cancer immunotherapySci. Transl. Med.202012eaay870710.1126/scitranslmed.aay8707Search in Google Scholar
Rayes R.F., Mouhanna J.G., Nicolau I., Bourdeau F., Giannias B., Rousseau S., Quail D., Walsh L., Sangwan V., Bertos N., et al.: Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. JCI Insight, 2019; 5: e128008.RayesR.F.MouhannaJ.G.NicolauI.BourdeauF.GianniasB.RousseauS.QuailD.WalshL.SangwanV.BertosN.Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effectsJCI Insight20195e12800810.1172/jci.insight.128008677783531343990Search in Google Scholar
Krakowska M., Debska-Szmich S., Czernek U., Czyzykowski R., Potemski P.: P-032 A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC). Ann. Oncol., 2016; 27: ii9.KrakowskaM.Debska-SzmichS.CzernekU.CzyzykowskiR.PotemskiP.P-032 A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC)Ann. Oncol.201627ii910.1093/annonc/mdw199.30Search in Google Scholar
Hore T.A.: Modulating epigenetic memory through vitamins and TET: Implications for regenerative medicine and cancer treatment. Epigenomics, 2017; 9: 863–871.HoreT.A.Modulating epigenetic memory through vitamins and TET: Implications for regenerative medicine and cancer treatmentEpigenomics2017986387110.2217/epi-2017-002128554227Search in Google Scholar
Guz J., Oliński R.: The role of vitamin C in epigenetic regulation. Postępy Hig. Med. Dośw., 2017; 71: 747–760.GuzJ.OlińskiR.The role of vitamin C in epigenetic regulationPostępy Hig. Med. Dośw.20177174776010.5604/01.3001.0010.385328894047Search in Google Scholar
Sant D.W., Mustafi S., Gustafson C.B., Chen J., Slingerland J.M., Wang G.: Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression. Sci. Rep., 2018; 8: 5306.SantD.W.MustafiS.GustafsonC.B.ChenJ.SlingerlandJ.M.WangG.Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expressionSci. Rep.20188530610.1038/s41598-018-23714-7587177229593282Search in Google Scholar
Shenoy N., Bhagat T.D., Cheville J., Lohse C., Bhattacharyya S., Tischer A., Machha V., Gordon-Mitchell S., Choudhary G., Wong L.F., et al.: Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma. J. Clin. Invest., 2019; 129: 1612–1625.ShenoyN.BhagatT.D.ChevilleJ.LohseC.BhattacharyyaS.TischerA.MachhaV.Gordon-MitchellS.ChoudharyG.WongL.F.Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaJ. Clin. Invest.20191291612162510.1172/JCI98747643686230702441Search in Google Scholar
Luchtel R.A., Bhagat T., Pradhan K., Jacobs W.R. Jr., Levine M., Verma A., Shenoy N.: High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc. Natl. Acad. Sci. USA, 2020; 117: 1666–1677.LuchtelR.A.BhagatT.PradhanK.JacobsW.R.Jr.LevineM.VermaA.ShenoyN.High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse modelProc. Natl. Acad. Sci. USA20201171666167710.1073/pnas.1908158117698341831911474Search in Google Scholar
Rubis B., Luczak M.W., Krawic C., Zhitkovich A.: Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin. Free Radic. Biol. Med., 2019; 136: 12–21.RubisB.LuczakM.W.KrawicC.ZhitkovichA.Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycinFree Radic. Biol. Med.2019136122110.1016/j.freeradbiomed.2019.03.026648835930926564Search in Google Scholar
Buettner G.R., Moseley P.L.: Ascorbate both activates and inactivates bleomycin by free radical generation. Biochemistry, 1992; 31: 9784–9788.BuettnerG.R.MoseleyP.L.Ascorbate both activates and inactivates bleomycin by free radical generationBiochemistry1992319784978810.1021/bi00155a0351382593Search in Google Scholar
Prasad K.N., Hernandez C., Edwards-Prasad J., Nelson J., Borus T., Robinson W.A.: Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-α2b on human melanoma cells in culture by a mixture of vitamins. Nutr. Cancer, 1994; 22: 233–245.PrasadK.N.HernandezC.Edwards-PrasadJ.NelsonJ.BorusT.RobinsonW.A.Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-α2b on human melanoma cells in culture by a mixture of vitaminsNutr. Cancer19942223324510.1080/016355894095143497877893Search in Google Scholar
Chiang C.D., Song E.J., Yang V.C., Chao C.C.: Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Biochem. J., 1994; 301: 759–764.ChiangC.D.SongE.J.YangV.C.ChaoC.C.Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cellsBiochem. J.199430175976410.1042/bj3010759Search in Google Scholar
Kurbacher C.M., Wagner U., Kolster B., Andreotti P.E., Krebs D., Bruckner H.W.: Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett., 1996; 103: 183–189.KurbacherC.M.WagnerU.KolsterB.AndreottiP.E.KrebsD.BrucknerH.W.Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitroCancer Lett.199610318318910.1016/0304-3835(96)04212-7Search in Google Scholar
Reddy V.G., Khanna N., Singh N.: Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem. Biophys. Res. Commun., 2001; 282: 409–415.ReddyV.G.KhannaN.SinghN.Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53Biochem. Biophys. Res. Commun.200128240941510.1006/bbrc.2001.459311401473Search in Google Scholar
Bhat S.H., Azmi A.S., Hanif S., Hadi S.M.: Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties. Int. J. Biochem. Cell Biol., 2006; 38: 2074–2081.BhatS.H.AzmiA.S.HanifS.HadiS.M.Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer propertiesInt. J. Biochem. Cell Biol.2006382074208110.1016/j.biocel.2006.05.01716861029Search in Google Scholar
Chen Q., Espey M.G., Sun A.Y., Pooput C., Kirk K.L., Krishna M.C., Khosh D.B., Drisko J., Levine M.: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA, 2008; 105: 11105–11109.ChenQ.EspeyM.G.SunA.Y.PooputC.KirkK.L.KrishnaM.C.KhoshD.B.DriskoJ.LevineM.Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProc. Natl. Acad. Sci. USA2008105111051110910.1073/pnas.0804226105251628118678913Search in Google Scholar
Schoenfeld J.D., Sibenaller Z.A., Mapuskar K.A., Wagner B.A., Cramer-Morales K.L., Furqan M., Sandhu S., Carlisle T.L., Smith M.C., Abu Hejleh T., et al.: O2⋅- and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell, 2017; 31: 487–500.e8.SchoenfeldJ.D.SibenallerZ.A.MapuskarK.A.WagnerB.A.Cramer-MoralesK.L.FurqanM.SandhuS.CarlisleT.L.SmithM.C.Abu HejlehT.O2⋅- and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbateCancer Cell201731487500.e810.1016/j.ccell.2017.07.00828810149Search in Google Scholar
Carr A.C., Cook J.: Intravenous vitamin C for cancer therapy – identifying the current gaps in our knowledge. Front Physiol., 2018; 9: 1182.CarrA.C.CookJ.Intravenous vitamin C for cancer therapy – identifying the current gaps in our knowledgeFront Physiol.20189118210.3389/fphys.2018.01182611550130190680Search in Google Scholar
Robitaille L., Mamer O.A., Miller W.H. Jr., Levine M., Assouline S., Melnychuk D., Rousseau C., Hoffer L.J.: Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism, 2009; 58: 263–269.RobitailleL.MamerO.A.MillerW.H. Jr., Levine M.AssoulineS.MelnychukD.RousseauC.HofferL.J.Oxalic acid excretion after intravenous ascorbic acid administrationMetabolism20095826326910.1016/j.metabol.2008.09.023348248719154961Search in Google Scholar
Günes–Bayir A., Kiziltan H.S.: Palliative vitamin C application in patients with radiotherapy-resistant bone metastases: A retrospective study. Nutr. Cancer, 2015; 67, 921–925.Günes–BayirA.KiziltanH.S.Palliative vitamin C application in patients with radiotherapy-resistant bone metastases: A retrospective studyNutr. Cancer20156792192510.1080/01635581.2015.105536626168394Search in Google Scholar
Ma Y., Chapman J., Levine M., Polireddy K., Drisko J., Chen Q.: High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci. Transl. Med., 2014; 6: 222ra18.MaY.ChapmanJ.LevineM.PolireddyK.DriskoJ.ChenQ.High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapySci. Transl. Med.20146222ra1810.1126/scitranslmed.300715424500406Search in Google Scholar
Takahashi H., Mizuno H., Yanagisawa A.: High-dose intravenous vitamin C improves quality of life in cancer patients. Personalized Medicine Universe, 2012; 1: 49–53.TakahashiH.MizunoH.YanagisawaA.High-dose intravenous vitamin C improves quality of life in cancer patientsPersonalized Medicine Universe20121495310.1016/j.pmu.2012.05.008Search in Google Scholar
Yeom C.H., Jung G.C., Song K.J.: Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. J. Korean Med. Sci., 2007; 22: 7-11.YeomC.H.JungG.C.SongK.J.Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administrationJ. Korean Med. Sci.20072271110.3346/jkms.2007.22.1.7269357117297243Search in Google Scholar
Stephenson C.M., Levin R.D., Spector T., Lis C.G.: Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother. Pharmacol., 2013; 72: 139–146.StephensonC.M.LevinR.D.SpectorT.LisC.G.Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancerCancer Chemother. Pharmacol.20137213914610.1007/s00280-013-2179-9369149423670640Search in Google Scholar
Cameron E., Pauling L.: Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA, 1978; 75: 4538–4542.CameronE.PaulingL.Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancerProc. Natl. Acad. Sci. USA1978754538454210.1073/pnas.75.9.4538336151279931Search in Google Scholar
Murata A., Morishige F., Yamaguchi H.: Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int. J. Vitam. Nutr. Res. Suppl., 1982; 23: 103–113.MurataA.MorishigeF.YamaguchiH.Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbateInt. J. Vitam. Nutr. Res. Suppl.198223103113Search in Google Scholar
Harris H.R., Bergkvist L., Wolk A.: Vitamin C intake and breast cancer mortality in a cohort of Swedish women. Br. J. Cancer, 2013; 109: 257–264.HarrisH.R.BergkvistL.WolkA.Vitamin C intake and breast cancer mortality in a cohort of Swedish womenBr. J. Cancer201310925726410.1038/bjc.2013.269370858323736027Search in Google Scholar
Vollbracht C., Schneider B., Leendert V., Weiss G., Auerbach L., Beuth J.: Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo, 2011; 25: 983–990.VollbrachtC.SchneiderB.LeendertV.WeissG.AuerbachL.BeuthJ.Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in GermanyIn Vivo201125983990Search in Google Scholar
Hoffer L.J., Levine M., Assouline S., Melnychuk D., Padayatty S.J., Rosadiuk K., Rousseau C., Robitaille L., Miller W.H. Jr.: Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann. Oncol., 2008; 19: 1969–1974.HofferL.J.LevineM.AssoulineS.MelnychukD.PadayattyS.J.RosadiukK.RousseauC.RobitailleL.MillerW.H. Jr.Phase I clinical trial of i.v. ascorbic acid in advanced malignancyAnn. Oncol.2008191969197410.1093/annonc/mdn37718544557Search in Google Scholar
Kiziltan H.S., Bayir A.G., Demirtas M., Meral I., Taspinar O., Eris A.H., Aydin T., Mayadagli A.: Ascorbic-acid treatment for progressive bone metastases after radiotherapy: A pilot study. Altern. Ther. Health Med., 2014; 20: 16–20.KiziltanH.S.BayirA.G.DemirtasM.MeralI.TaspinarO.ErisA.H.AydinT.MayadagliA.Ascorbic-acid treatment for progressive bone metastases after radiotherapy: A pilot studyAltern. Ther. Health Med.2014201620Search in Google Scholar
Polireddy K., Dong R., Reed G., Yu J., Chen P., Williamson S., Violet P.C., Pessetto Z., Godwin A.K., Fan F., et al.: High Dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: Mechanisms and a phase I/IIa study. Sci. Rep., 2017; 7: 17188.PolireddyK.DongR.ReedG.YuJ.ChenP.WilliamsonS.VioletP.C.PessettoZ.GodwinA.K.FanF.High Dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: Mechanisms and a phase I/IIa studySci. Rep.201771718810.1038/s41598-017-17568-8571936429215048Search in Google Scholar
Welsh J.L., Wagner B.A., van’t Erve T.J., Zehr P.S., Berg D.J., Halfdanarson T.R., Yee N.S., Bodeker K.L., Du J., Roberts L.J. 2nd, et al.: Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trial. Cancer Chemother. Pharmacol., 2013; 71: 765–775.WelshJ.L.WagnerB.A.van’t ErveT.J.ZehrP.S.BergD.J.HalfdanarsonT.R.YeeN.S.BodekerK.L.DuJ.RobertsL.J. 2ndPharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trialCancer Chemother. Pharmacol.20137176577510.1007/s00280-013-2070-8358704723381814Search in Google Scholar
Pinkerton E., Good P., Gibbons K., Hardy J.: An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer. Support Care Cancer, 2017; 25: 341–343.PinkertonE.GoodP.GibbonsK.HardyJ.An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancerSupport Care Cancer20172534134310.1007/s00520-016-3472-z27815713Search in Google Scholar
Berenson J.R., Yellin O., Woytowitz D., Flam M.S., Cartmell A., Patel R., Duvivier H., Nassir Y., Eades B., Abaya C.D., et al.: Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: An effective and well-tolerated frontline regimen. Eur. J. Haematol., 2009; 82: 433–439.BerensonJ.R.YellinO.WoytowitzD.FlamM.S.CartmellA.PatelR.DuvivierH.NassirY.EadesB.AbayaC.D.Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: An effective and well-tolerated frontline regimenEur. J. Haematol.20098243343910.1111/j.1600-0609.2009.01244.x19226361Search in Google Scholar
Riordan H.D., Casciari J.J., González M.J., Riordan N.H., Miranda-Massari J.R., Taylor P., Jackson J.A.: A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P. R. Health Sci. J., 2005; 24: 269–276.RiordanH.D.CasciariJ.J.GonzálezM.J.RiordanN.H.Miranda-MassariJ.R.TaylorP.JacksonJ.A.A pilot clinical study of continuous intravenous ascorbate in terminal cancer patientsP. R. Health Sci. J.200524269276Search in Google Scholar
Nielsen T.K., Højgaard M., Andersen J.T., Jørgensen N.R., Zerahn B., Kristensen B., Henriksen T., Lykkesfeldt J., Mikines K.J., Poulsen H.E.: Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: A single-arm phase II trial. Transl. Androl. Urol., 2017; 6: 517–528.NielsenT.K.HøjgaardM.AndersenJ.T.JørgensenN.R.ZerahnB.KristensenB.HenriksenT.LykkesfeldtJ.MikinesK.J.PoulsenH.E.Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: A single-arm phase II trialTransl. Androl. Urol.2017651752810.21037/tau.2017.04.42Search in Google Scholar
Zhao H., Zhu H., Huang J., Zhu Y., Hong M., Zhu H., Zhang J., Li S., Yang L., Lian Y., et al.: The synergy of vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk. Res., 2018; 66: 1–7.ZhaoH.ZhuH.HuangJ.ZhuY.HongM.ZhuH.ZhangJ.LiS.YangL.LianY.The synergy of vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemiaLeuk. Res.2018661710.1016/j.leukres.2017.12.009Search in Google Scholar
Goel S., Agarwal S.B., Mandal A.K., Singhal K., Agarwal T.: Emerging role of ascorbic acid in the management of advanced breast carcinoma as a chemosensitizer. Asian J. Surg., 1999; 22: 333–336.GoelS.AgarwalS.B.MandalA.K.SinghalK.AgarwalT.Emerging role of ascorbic acid in the management of advanced breast carcinoma as a chemosensitizerAsian J. Surg.199922333336Search in Google Scholar
Jeon Y., Park J.S., Moon S., Yeo J.: Effect of intravenous high dose vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial. Pain Res. Manag., 2016; 2016: 9147279.JeonY.ParkJ.S.MoonS.YeoJ.Effect of intravenous high dose vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trialPain Res. Manag.20162016914727910.1155/2016/9147279Search in Google Scholar
Creagan E.T., Moertel C.G., O’Fallon J.R., Schutt A.J., O’Connell M.J., Rubin J., Frytak S:. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med., 1979; 301: 687–690.CreaganE.T.MoertelC.G.O’FallonJ.R.SchuttA.J.O’ConnellM.J.RubinJ.FrytakS.Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialN. Engl. J. Med.197930168769010.1056/NEJM197909273011303Search in Google Scholar
Moertel C.G., Fleming T.R., Creagan E.T., Rubin J., O’Connell M.J., Ames M.M.: High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med., 1985; 312: 137-141.MoertelC.G.FlemingT.R.CreaganE.T.RubinJ.O’ConnellM.J.AmesM.M.High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonN. Engl. J. Med.198531213714110.1056/NEJM198501173120301Search in Google Scholar
Zemskov V.S., Procopchuk O.L., Susak Y.M., Zemskov S.V., Hodysh Y.Y., Zemskova M.V.: Ukrain (NSC-631570) in the treatment of pancreas cancer. Drugs Exp. Clin. Res., 2000; 26: 179–190.ZemskovV.S.ProcopchukO.L.SusakY.M.ZemskovS.V.HodyshY.Y.ZemskovaM.V.Ukrain (NSC-631570) in the treatment of pancreas cancerDrugs Exp. Clin. Res.200026179190Search in Google Scholar
Cameron E., Campbell A.: The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem. Biol. Interact, 1974; 9: 285–315.CameronE.CampbellA.The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChem. Biol. Interact1974928531510.1016/0009-2797(74)90019-2Search in Google Scholar
Carr A.C., McCall C.: The role of vitamin C in the treatment of pain: New insights. J. Transl. Med., 2017; 15: 77.CarrA.C.McCallC.The role of vitamin C in the treatment of pain: New insightsJ. Transl. Med.2017157710.1186/s12967-017-1179-7539156728410599Search in Google Scholar
Jarosz M., Rychlik E., Stoś K., Charzewska J. (eds.): Normy żywienia dla populacji Polski i ich zastosowanie. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Warszawa 2020.JaroszM.RychlikE.StośK.CharzewskaJ.Normy żywienia dla populacji Polski i ich zastosowanieNarodowy Instytut Zdrowia Publicznego – Państwowy Zakład HigienyWarszawa2020Search in Google Scholar
Lykkesfeldt J., Poulsen H.E.: Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br. J. Nutr., 2010; 103: 1251–1259.LykkesfeldtJ.PoulsenH.E.Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trialsBr. J. Nutr.20101031251125910.1017/S000711450999322920003627Search in Google Scholar